NEDD8 Inhibitors

MLN4924 is a potent and selective inhibitor of NEDD8-activating enzyme (NAE). It hinders the neddylation process, preventing the attachment of NEDD8 to target proteins. By specifically targeting NAE, MLN4924 disrupts the NEDD8 conjugation pathway, leading to the inhibition of cullin-RING ligases (CRLs) and subsequent modulation of various cellular processes reliant on CRL-mediated ubiquitination.

Panobinostat is a histone deacetylase (HDAC) inhibitor that indirectly influences NEDD8 by altering the acetylation status of proteins involved in neddylation. It modifies the acetylation levels of histones and non-histone proteins, affecting the transcription of genes associated with the NEDD8 pathway.

Auranofin, traditionally used as an anti-rheumatic agent, exhibits potential as an indirect NEDD8 inhibitor. It impacts the redox state of the cell by inhibiting thioredoxin reductase, leading to oxidative stress and alterations in cellular signaling pathways. The oxidative environment created by Auranofin influences the expression and activity of proteins involved in the NEDD8 pathway, indirectly affecting NEDD8 conjugation to target proteins.

This MLN4924 analog acts as a structural mimic of MLN4924 and competitively inhibits NAE. By resembling the binding interface of MLN4924, this analog disrupts the neddylation process, preventing the transfer of NEDD8 to target proteins.

Bortezomib, a proteasome inhibitor, indirectly impacts NEDD8 by disrupting the ubiquitin-proteasome system. It inhibits the 26S proteasome, preventing the degradation of ubiquitinated proteins, including those targeted for NEDD8-dependent ubiquitination.

MLN7243 is a selective inhibitor of the NEDD8-activating enzyme (NAE) and serves as an analog to MLN4924. By inhibiting NAE, MLN7243 disrupts the neddylation process, preventing the attachment of NEDD8 to target proteins. The specific targeting of NAE by MLN7243 leads to the inhibition of cullin-RING ligases (CRLs), affecting the ubiquitin-proteasome system and modulating cellular processes reliant on CRL-mediated ubiquitination.

NSC697923, a potent inhibitor of the COP9 signalosome (CSN), indirectly influences NEDD8 by disrupting the CSN-mediated deneddylation of cullin proteins. By inhibiting CSN, NSC697923 prevents the removal of NEDD8 from cullins, leading to the accumulation of neddylated cullins and modulation of CRL activity.

JQ-1, a selective BET bromodomain inhibitor, indirectly influences NEDD8 by altering the expression of key regulatory proteins in the NEDD8 pathway. Through the modulation of gene expression, JQ-1 affects the levels of proteins involved in neddylation, indirectly influencing NEDD8 conjugation to target proteins.

NMS-873 is a selective and potent inhibitor of p97, an AAA-ATPase involved in protein degradation. By targeting p97, NMS-873 disrupts the ubiquitin-proteasome system, indirectly influencing NEDD8 by altering the degradation of proteins targeted for NEDD8-dependent ubiquitination.

The MLN4924 prodrug, upon activation, serves as a precursor to MLN4924, a specific inhibitor of NAE. Once metabolized, the prodrug releases MLN4924, which then inhibits NAE, disrupting the neddylation process. This inhibitory effect prevents the attachment of NEDD8 to target proteins, leading to the inhibition of CRLs and subsequent modulation of cellular processes reliant on CRL-mediated ubiquitination.